Photo from Biagio Ricciuti/X
Apr 9, 2024, 13:33
Biagio Ricciuti: If you are at AACR24, stop by poster 21 (section 1) to learn more about the discovery of ALK-specific TCR clonotypes
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter:
”If you are at AACR24, stop by poster 21 (section 1) to learn more about the discovery of ALK-specific TCR clonotypes for the development of TCR-T cell therapies against ALK-positive cancers! Amazing study led by Carmen Mecca.”
Source: Biagio Ricciuti/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 10, 2024, 15:23
Oct 10, 2024, 15:08
Oct 10, 2024, 14:55
Oct 10, 2024, 14:29
Oct 10, 2024, 14:23
Oct 10, 2024, 14:21
Oct 10, 2024, 14:07
Oct 10, 2024, 13:19